Glioblastoma (GBM) is one of the most aggressive malignant tumors with an overall dismal
survival averaging one year despite multimodality therapeutic interventions including …

Simple Summary Glioblastoma (GBM) is a tumor of the brain or spinal cord with poor clinical
prognosis. Current interventions, such as chemotherapy and surgical tumor resection, are …

Simple Summary Glioblastoma multiforme (GBM) is one of the belligerent neoplasia that
metastasize to other brain regions and invade nearby healthy tissues. However, the …

Glioblastoma (GBM) is the most common and aggressive brain tumor, which causes the
highest number of deaths worldwide. It is a highly vascularized tumor, infiltrative, and its …

Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most
aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior …

Glioblastoma multiforme (GBM) is the most frequent, primary malignant brain tumor
prevalent in humans. GBM characteristically exhibits aggressive cell proliferation and rapid …

Glioblastoma multiforme (GBM) is the deadliest and the most heterogeneous brain cancer.
The median survival time of GBM patients is approximately 8 to 15 months after initial …

Despite relevant progress obtained by multimodal treatment, glioblastoma (GBM), the most
aggressive primary brain tumor, is still incurable. The most encouraging advancement of …

Common care for glioblastoma multiforme (GBM) is a surgical resection followed by
radiotherapy and temozolomide‐(TMZ‐) based chemotherapy. Unfortunately, these …

Glioblastoma multiforme is one of the most deadly malignant tumors, with more than 10,000
cases recorded annually in the United States. Various clinical analyses and studies show …